MyAverix Finance
SHG · Healthcare
Shandong Buchang Pharmaceuticals Co Ltd (603858)
Drug Manufacturers - Specialty & Generic
Shandong Buchang Pharmaceuticals Co Ltd (603858) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $17.19B, P/E ratio is 815.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603858
Shandong Buchang Pharmaceuticals Co Ltd (603858) — FAQ
What is Shandong Buchang Pharmaceuticals Co Ltd's market cap?
Shandong Buchang Pharmaceuticals Co Ltd (603858) has a reported market cap of $17.19B (data as of 2026-03-29).
What is 603858's P/E ratio?
The price-to-earnings (P/E) ratio for Shandong Buchang Pharmaceuticals Co Ltd (603858) is 815.00 (data as of 2026-03-29).
Does Shandong Buchang Pharmaceuticals Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Shandong Buchang Pharmaceuticals Co Ltd (603858). Check the MyAverix Finance app for the latest dividend data.
What sector is Shandong Buchang Pharmaceuticals Co Ltd in?
Shandong Buchang Pharmaceuticals Co Ltd (603858) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603858 listed on?
603858 is listed on SHG.
What is Shandong Buchang Pharmaceuticals Co Ltd's net margin?
Shandong Buchang Pharmaceuticals Co Ltd (603858) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.